{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:59:01Z","timestamp":1793127541319,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.amjcard.2026.02.030","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:39:33Z","timestamp":1772095173000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment"],"prefix":"10.1016","volume":"267","author":[{"given":"Ahmed Farid","family":"Gadelmawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Diaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Abouzkaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriti","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raveena","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth P.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Passey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.02.030_bib0001","series-title":"Obesity and Comorbid Conditions","author":"Lim","year":"2025"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0002","doi-asserted-by":"crossref","DOI":"10.1186\/s12245-022-00431-7","article-title":"Medical complications of obesity: heightened importance in a COVID era","volume":"15","author":"Prendergast","year":"2022","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0003","unstructured":"Obesity. Accessed July 15, 2025. https:\/\/www.who.int\/health-topics\/obesity"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0004","unstructured":"Obesity and overweight. Accessed July 15, 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"issue":"5","key":"10.1016\/j.amjcard.2026.02.030_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0006","series-title":"Endotext.","article-title":"Molecular links between obesity and diabetes: \u201cdiabesity.\u201d","author":"Chadt","year":"2000"},{"issue":"4","key":"10.1016\/j.amjcard.2026.02.030_bib0007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4239\/wjd.v14.i4.396","article-title":"Management of diabesity: current concepts","volume":"14","author":"Michaelidou","year":"2023","journal-title":"World J Diabetes"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0008","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"<p>obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications<\/p>","volume":"13","author":"Wondmkun","year":"2020","journal-title":"DMSO"},{"issue":"7","key":"10.1016\/j.amjcard.2026.02.030_bib0009","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/clinem\/dgab091","article-title":"Long-term weight loss strategies for obesity","volume":"106","author":"Kheniser","year":"2021","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0010","series-title":"StatPearls","article-title":"Exercise and Fitness Effect on Obesity","author":"Niemiro","year":"2025"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0011","series-title":"StatPearls","article-title":"Dietary Approaches to Obesity Treatment","author":"Parmar","year":"2025"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0012","series-title":"Endotext","article-title":"Pharmacologic treatment of overweight and obesity in adults","author":"Tchang","year":"2000"},{"issue":"2","key":"10.1016\/j.amjcard.2026.02.030_bib0013","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological Management of obesity: an Endocrine Society Clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocrine Pract"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0015","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review","author":"Hamed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0016","series-title":"StatPearls","article-title":"Semaglutide","author":"Kommu","year":"2025"},{"issue":"11","key":"10.1016\/j.amjcard.2026.02.030_bib0017","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CRD.0000000000000513","article-title":"Cagrilintide: a long-acting amylin analog for the treatment of obesity","volume":"32","author":"D\u2019Ascanio","year":"2024","journal-title":"Cardiology in Review"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","author":"Garvey","year":"2025","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.amjcard.2026.02.030_bib0021","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4103\/ijem.ijem_45_24","article-title":"Efficacy and safety of cagrilintide alone and in combination with semaglutide (Cagrisema) as anti-obesity medications: a systematic review and meta-analysis","volume":"28","author":"Dutta","year":"2024","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0022","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0023","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions (current version) | Cochrane. Accessed July 5, 2025. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0024","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0025","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.amjcard.2026.02.030_bib0026","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ : British Medical Journal"},{"issue":"3","key":"10.1016\/j.amjcard.2026.02.030_bib0027","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/1359-0189(90)90036-W","article-title":"The radial plot: graphical assessment of spread in ages","volume":"17","author":"Galbraith","year":"1990","journal-title":"Int J Radiat Appl Instrument Part D Nuclear Tracks Radiat Measurements"},{"issue":"4","key":"10.1016\/j.amjcard.2026.02.030_bib0028","first-page":"195","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"JBI Evid Implementation"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0029","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide\u2013Semaglutide in adults with overweight or obesity and type 2 diabetes","author":"Davies","year":"2025","journal-title":"N Engl J Med."},{"issue":"10403","key":"10.1016\/j.amjcard.2026.02.030_bib0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2\u00b74 mg with once-weekly semaglutide 2\u00b74 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"The Lancet"},{"issue":"10286","key":"10.1016\/j.amjcard.2026.02.030_bib0031","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2\u00b74 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14863","article-title":"Semaglutide for the treatment of overweight and obesity: a review","volume":"25","author":"Bergmann","year":"2023","journal-title":"Diabetes Obesity Metab"},{"issue":"6","key":"10.1016\/j.amjcard.2026.02.030_bib0033","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s13300-025-01733-8","article-title":"Amylin: from mode of action to future clinical potential in diabetes and obesity","volume":"16","author":"Vol\u010dan\u0161ek","year":"2025","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0034","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"issue":"10499","key":"10.1016\/j.amjcard.2026.02.030_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(25)01185-7","article-title":"Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b\/2a randomised controlled study","volume":"406","author":"Dahl","year":"2025","journal-title":"The Lancet"},{"issue":"20","key":"10.1016\/j.amjcard.2026.02.030_bib0036","first-page":"1953","article-title":"ACC scientific statement on the managment ofobesity in adults with heart failure: a report of the american college of cardiology","volume":"86","author":"Kittleson","year":"2025","journal-title":"JAAC"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2025.100185","article-title":"Knowledge, attitudes, and practices in obesity among trained and in-training primary care providers in an urban safety-net hospital system","volume":"15","author":"Campos","year":"2025","journal-title":"Obesity Pillars"},{"issue":"7","key":"10.1016\/j.amjcard.2026.02.030_bib0038","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"Concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the american college of cardiology solution set oversight commitee","volume":"86","author":"Gilbert","year":"2025","journal-title":"JACC"},{"issue":"11","key":"10.1016\/j.amjcard.2026.02.030_bib0039","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamasurg.2016.2317","article-title":"Bariatric surgery and long-term durability of weight loss","volume":"151","author":"Maciejewski","year":"2016","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.amjcard.2026.02.030_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/jcm10040745","article-title":"Changes in body composition are associated with metabolic Changes and the risk of metabolic syndrome","volume":"10","author":"Oh","year":"2021","journal-title":"JCM"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04143-6","article-title":"Increased weight-load improves body composition by reducing fat mass and waist circumference, and by increasing lean mass in participants with obesity: a single-centre randomised controlled trial","volume":"23","author":"Bellman","year":"2025","journal-title":"BMC Med"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110881","article-title":"The role of weight control in the management of type 2 diabetes mellitus: perspectives on semaglutide","volume":"203","author":"Kurtzhals","year":"2023","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0043","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/IPRP.S503501","article-title":"Molecular pharmacology of glucagon-like peptide 1-based therapies in the management of type two diabetes mellitus and obesity","volume":"14","author":"Alzahrani","year":"2025","journal-title":"IPRP"},{"issue":"15","key":"10.1016\/j.amjcard.2026.02.030_bib0044","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of Cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0045","series-title":"Weight Management: State of the Science and Opportunities for Military Programs","article-title":"Weight-loss and maintenance strategies","year":"2004"},{"issue":"3\u20134","key":"10.1016\/j.amjcard.2026.02.030_bib0046","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"issue":"6","key":"10.1016\/j.amjcard.2026.02.030_bib0047","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0048","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0049","doi-asserted-by":"crossref","first-page":"bqae155","DOI":"10.1210\/endocr\/bqae155","article-title":"Physiology and pharmacology of effects of GLP-1-based therapies on gastric, biliary and intestinal motility","volume":"166","author":"Jalleh","year":"2025","journal-title":"Endocrinology"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0050","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.2147\/DDDT.S365416","article-title":"Clinical insight on Semaglutide for chronic weight management in adults: patient selection and special considerations","volume":"16","author":"Chao","year":"2022","journal-title":"DDDT"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0051","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"122","author":"Mozaffarian","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.amjcard.2026.02.030_bib0052","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-19-0893","article-title":"European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity","volume":"182","author":"Pasquali","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjcard.2026.02.030_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177850","article-title":"Recent progress in the pharmacotherapy for obesity","volume":"1002","author":"Lu","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.amjcard.2026.02.030_bib0056","doi-asserted-by":"crossref","first-page":"138","DOI":"10.17085\/apm.21038","article-title":"Trial sequential analysis: novel approach for meta-analysis","volume":"16","author":"Kang","year":"2021","journal-title":"Anesth Pain Med (Seoul)"},{"issue":"6","key":"10.1016\/j.amjcard.2026.02.030_bib0057","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jrsm.1504","article-title":"Meta-regression methods to characterize evidence strength using meaningful-effect percentages conditional on study characteristics","volume":"12","author":"Mathur","year":"2021","journal-title":"Res Synthesis Methods"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:25:59Z","timestamp":1777119959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S0002914926000858"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}